Status:
COMPLETED
Coronary Artery Bypass Graft (CABG) Patch Trial
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Arrhythmia
Cardiovascular Diseases
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
To test the hypothesis that implantable cardioverter defibrillator (ICD) therapy will improve survival in coronary heart disease patients at high risk of death, especially arrhythmic death.
Detailed Description
BACKGROUND: Management strategies are urgently needed for the problem of sudden cardiac death, the most common single, non-accidental cause of death in adults in North America. Many consider that the...
Eligibility Criteria
Men and women, up to age 80, with a left ventricular ejection fraction less than .36 and an abnormal signal averaged electrocardiogram.
Key Trial Info
Start Date :
December 1 1992
Trial Type :
INTERVENTIONAL
End Date :
December 1 1998
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000540
Start Date
December 1 1992
End Date
December 1 1998
Last Update
November 7 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.